ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 63878 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 63878; 2) Community: the network communities that were significantly associated with the response to NSC 63878; 3) Molecule: the relationships between components within communities and NSC 63878; 4) MDR: the compounds that were significantly associated with the NSC 63878.

NSC Compound Enrichment Correlation
NSC 119915 3-(4,5,6-trihydroxy-3-oxo-3H-xanthen-9-yl)propanoic acid 0.0297837393005856 0.17429827
NSC 148790 Card-20(22)-enolide, 16-(acetyloxy)-3,14-dihydroxy-, (3.beta.,5.beta.,16.beta.)- (9CI) 0.0297837393005856 0.47837024
NSC 154948 M-AMSA 0.0297837393005856 0.63996216
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0297837393005856 0.38786347
NSC 254665 JUSTICIDIN B 0.0297837393005856 0.22167683
NSC 3077 s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.0297837393005856 0.37453667
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0297837393005856 0.59549937
NSC 603071 Aminocamptothecin 0.0297837393005856 0.72437743
NSC 603578 Platinum, tetrachloro[dimethylsilylenebis(methanamine)]-, (OC-6-22) 0.0297837393005856 0.5901963
NSC 606497 Camptothecin Derivative 0.0297837393005856 0.75883818
Total:67  Current:42    [First] [Prev] [Next] [Last]